Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial

Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial

Abstract Background Currently, there are no medications approved for the treatment of juvenile fibromyalgia (JFM). We evaluated the safety and efficacy of duloxetine 30/60 mg once daily (QD) versus placebo in adolescents with JFM. Methods In this Phase 3b, multisite (US, Argentina, Puerto Rico, and...

Full description

Bibliographic Details
Main Authors: Himanshu P. Upadhyaya, Lesley M. Arnold, Karla Alaka, Meihua Qiao, David Williams, Renata Mehta
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Juvenile fibromyalgia
Duloxetine
Serotonin and norepinephrine reuptake inhibitor
Online Access:http://link.springer.com/article/10.1186/s12969-019-0325-6

Internet

http://link.springer.com/article/10.1186/s12969-019-0325-6

Similar Items